Piper Jaffray upgrades Genzyme Corporation (Nasdaq: GENZ) from Neutral to Overweight and raised their price target from $65 to $66.
This article: 119 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE